Lindbrook Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $115K | Hold |
900
| – | – | 0.01% | 623 |
|
|
2024
Q4 | $119K | Sell |
900
-150
| -14% | -$19.8K | 0.01% | 511 |
|
|
2024
Q3 | $153K | Hold |
1,050
| – | – | 0.01% | 448 |
|
|
2024
Q2 | $144K | Hold |
1,050
| – | – | 0.01% | 432 |
|
|
2024
Q1 | $144K | Hold |
1,050
| – | – | 0.01% | 435 |
|
|
2023
Q4 | $143K | Hold |
1,050
| – | – | 0.01% | 421 |
|
|
2023
Q3 | $128K | Hold |
1,050
| – | – | 0.01% | 407 |
|
|
2023
Q2 | $133K | Sell |
1,050
-5
| -0.5% | -$635 | 0.01% | 416 |
|
|
2023
Q1 | $136K | Buy |
1,055
+5
| +0.5% | +$646 | 0.02% | 399 |
|
|
2022
Q4 | $138K | Hold |
1,050
| – | – | 0.02% | 417 |
|
|
2022
Q3 | $123K | Hold |
1,050
| – | – | 0.02% | 390 |
|
|
2022
Q2 | $124K | Hold |
1,050
| – | – | 0.02% | 401 |
|
|
2022
Q1 | $137K | Hold |
1,050
| – | – | 0.02% | 381 |
|
|
2021
Q4 | $160K | Buy |
+1,050
| New | +$160K | 0.02% | 361 |
|